ESOP29 May 2026, 07:31 pm
Crescentis Capital Grants 5 Lakh Stock Options to MD
AI Summary
Crescentis Capital Ltd has granted 5,00,000 stock options to Mr. Subba Rao Veera Venkata Meka, Managing Director, under the Crescentis Capital Limited Employees’ Stock Option Scheme, 2025 (“CCL ESOS 2025”). The grant was approved by the Nomination and Remuneration Committee and subsequently taken on record by the Board of Directors on May 29, 2026. The exercise price per option is ₹50. The options will vest in two tranches: 50% on May 28, 2027, and the remaining 50% on May 28, 2028.
Key Highlights
- Crescentis Capital grants 5,00,000 stock options to Managing Director.
- Options granted under CCL ESOS 2025 with an exercise price of ₹50 per option.
- Vesting schedule: 50% on May 28, 2027, and 50% on May 28, 2028.
- Scheme implemented through the direct route, in accordance with SEBI regulations.
- BSE approved listing of up to 13,00,000 equity shares under CCL ESOS 2025.
Price Impact
More from SODFC